NHLBI Home | News and Events Center | FYI Contents
Research and Resources
|
Sleep Curriculum Developed
Spotlight on Our Web Site
NHLBI Research Initiatives
- Clinical Centers for a Clinical Research Network for the Treatment
of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)
- Community-responsive Interventions to Reduce Cardiovascular Risk in
American Indians and Alaska Natives
- Exploratory and Developmental Research Grants for Investigations in
Rare Diseases (R21)
- Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
- Mechanisms of HIV-related Pulmonary Complications
- NHLBI Clinical Proteomics Programs
- Novel Targets and Therapy Development for Ischemic Stroke
- Pathogenesis and Treatment of Lymphedema and Lymphatic Diseases
- Prevention and Treatment of Childhood Obesity in Primary Care Settings
- Specialized Centers for Cell-based Therapy for Heart, Lung, and Blood
Diseases and Data and Coordinating Center
- Specialized Centers of Clinically Oriented Research (SCCOR) in Hemostatic
and Thrombotic Diseases
- SCCOR in Transfusion Biology and Medicine
Need More Information?
|
Sleep Curriculum Developed
As high school students throughout the country return to their classrooms this
fall, many will have to adjust their sleep habits considerably if they hope
to make it to school on time. To help parents and their children understand
and fully appreciate the importance of sleep, the NHLBI and the NIH Office of
Science Education developed a supplemental curriculum for use in high school
biology classes. The free curriculum, Sleep, Sleep Disorders, and Biological
Rhythms, encourages students to explore the scientific processes of sleep,
the importance of adequate sleep, and the negative consequences of not getting
enough sleep.
Teaching young people about the importance of adequate sleep is an educational
priority of the National Center on Sleep Disorders Research (NCSDR), which is
part of the NHLBI. Experts recommend at least nine hours of sleep per night
for all school-aged children. “Inadequate sleep not only makes us tired,
but also can make it difficult for us to concentrate, to learn, and to control
our impulses and emotions,” said Dr. Carl Hunt, Director, NCSDR.
Additional information on the curriculum supplement is available at Sleep
Curriculum. To learn about other curriculum supplements available from the
NIH, visit Educational
Supplements.
Spotlight on Our Web Site
A new Web resource for health information is available for patients and the
public. Developed by the NHLBI, the Diseases and Conditions Index (DCI) provides
information on diseases and conditions related to heart, lung, and blood diseases
and sleep disorders. New topics are being added and, when completed, the DCI
will feature more than 300 diseases and conditions. To explore this easy-to-use
resource, visit DCI.
NHLBI Research Initiatives
From time to time, the NHLBI invites investigators to submit grant applications
or contract proposals for specific research programs. We are currently soliciting
applications for the programs described below. For a full details of these and
other research initiatives, visit www.nhlbi.nih.gov/funding/inits/index.htm
or the Web page that is linked each initiative number.
Clinical Centers for a Clinical Research Network for the Treatment of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)
- Initiative Number: RFP-NHLBI-HR-05-04
- Applications due: October 8, 2004
- Objective: To develop and conduct clinical trials in the intensive care
unit to prevent, treat, and improve the outcome of patients with ALI/ARDS
and other related critical illnesses.
Community-responsive Interventions to Reduce Cardiovascular Risk in American Indians and Alaska Natives
- Initiative Number: RFA-HL-04-023
- Applications due: October 22, 2004
- Objective: To test behavioral interventions for cardiovascular health promotion
in Native communities.
Exploratory and Developmental Research Grants for Investigations in Rare Diseases (R21)
- Initiative Number: PA-03-171
- Objective: To encourage new approaches to understanding, treating, and preventing
rare heart, lung, and blood diseases and sleep disorders.
Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
- Initiative Number: RFA-HL-04-032
- Applications due: January 14, 2005
- Objective: To stimulate research to improve therapy and enhance understanding
of immune response and safety issues related to new gene transfer, cell-based,
or other therapies for bleeding.
Mechanisms of HIV-related Pulmonary Complications
- Initiative Number:
RFA-HL-04-031
- Applications due: March 16, 2005
- Objective: To encourage innovative research on the roles of co-infections,
immune factors, and genetic predisposition in the pathogenesis of HIV-related
pulmonary diseases.
NHLBI Clinical Proteomics Programs
- Initiative Number:
RFA-HL-04-019
- Applications due: October 14, 2004
- Objective: To promote systematic, comprehensive, large-scale validation
of existing and new candidate protein markers that are appropriate for routine
use in the diagnosis and management of heart, lung, and blood diseases and
sleep disorders.
Novel Targets and Therapy Development for Ischemic Stroke
- Initiative Number:
RFA-HL-05-004
- Applications due: January 11, 2005
- Objective: To develop safe and effective therapies to improve clinical management
of stroke patients.
Pathogenesis and Treatment of Lymphedema and Lymphatic Diseases
- Initiative Number: PA-04-071
- Applications are accepted for February 1, June 1, and October 1 deadlines
each year.
- Objectives: To identify the developmental, molecular, and cellular mechanisms
that contribute to lymphedema and develop effective therapeutic interventions.
Prevention and Treatment of Childhood Obesity in Primary Care Settings
- Initiative Number: RFA-HD-04-020
- Applications due: November 23, 2004
- Objective: To improve dietary and physical activity behaviors with the goal
of preventing excessive weight gain in at-risk children and/or promoting weight
loss in obese children.
Specialized Centers for Cell-based Therapy for Heart, Lung, and Blood Diseases
and Data and Coordinating Center
- Initiative Number:
RFA-HL-04-017
- Applications due: September 21, 2004
- Objective: To foster multidisciplinary research on cell based therapies
that will enable basic science findings to be more rapidly applied to clinical
problems.
Specialized Centers of Clinically Oriented Research (SCCOR) in Hemostatic
and Thrombotic Diseases
- Initiative Number:
RFA-HL-04-016
- Applications due: September 21, 2004
- Objective: To foster multidisciplinary research that enables basic science findings to be more
rapidly applied to the prevention, diagnosis, and treatment of thrombotic and bleeding disorders.
SCCOR in Transfusion Biology and Medicine
- Initiative Number: RFA-HL-04-018
- Applications due: September 21, 2004
- Objectives: To support the development and application of new knowledge
essential for improved safety, efficacy, and availability of blood, blood components,
and plasma derivatives, and to transfer these findings into clinical evaluation
and application.
Need More Information?
We are always interested in receiving comments and suggestions from the community.
If you or your organizations have questions for me or for the Institute, please
contact me at alvingb@nih.gov or Dr. Carl
Roth at rothc@nih.gov.
Barbara Alving, M.D.
Acting Director, NHLBI
For information on specific issues, the following contacts may be helpful:
For health related questions and publications,
please contact the trained information specialists
at the NHLBI Information Center
(NHLBIinfo@nhlbi.nih.gov) or write to the Information Center at P.O. Box 30105,
Bethesda, MD 20824-0105.
For
communications pertaining to NHLBI policies and
priorities, contact the NHLBI Office
of Public Liaison, (nhlbi.listens@nih.gov).
For
additional information regarding NHLBI events, consult the references provided
or NHLBI Calendar. Most other NIH Institutes
and Centers also maintain calendars on their Web sites. Links to their Web pages
are at NIH Institutes,
Centers, and Offices.
For
Web related matters pertaining
to the online version of the FYI from the NHLBI, contact the FYI
from the NHLBI's Web Editor.